These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10773768)

  • 1. Screening for DSM-IV somatoform disorders in chronic pain patients.
    Bankier B; Aigner M; Krones S; Bach M
    Psychopathology; 2000; 33(3):115-8. PubMed ID: 10773768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of DSM-IV pain disorder.
    Aigner M; Bach M
    Compr Psychiatry; 1999; 40(5):353-7. PubMed ID: 10509617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severity.
    Wedekind D; Bandelow B; Fentzahn E; Trümper P; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 2007 Apr; 257(3):153-63. PubMed ID: 17203236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determinants of quality of life in patients with somatoform disorders with pain as main symptom - the case for differentiating subgroups].
    Nickel R; Hardt J; Kappis B; Schwab R; Egle UT
    Z Psychosom Med Psychother; 2010; 56(1):3-22. PubMed ID: 20229488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms.
    Smith RC; Gardiner JC; Lyles JS; Sirbu C; Dwamena FC; Hodges A; Collins C; Lein C; Given CW; Given B; Goddeeris J
    Psychosom Med; 2005; 67(1):123-9. PubMed ID: 15673634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Spanish version of the Screening for Somatoform Symptoms-2 scale for use in Primary Care].
    Gili M; Bauzá N; Vives M; Moreno S; Magallón R; Roca M
    Aten Primaria; 2015 May; 47(5):273-8. PubMed ID: 25234152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain in somatoform disorders: is somatoform pain disorder a valid diagnosis?
    Birket-Smith M; Mortensen EL
    Acta Psychiatr Scand; 2002 Aug; 106(2):103-8. PubMed ID: 12121207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Explanatory Model-Interview in the diagnosis of orthopaedic pain patients].
    Schröter C; Schiltenwolf M; Fydrich T; Henningsen P
    Orthopade; 2004 May; 33(5):533-44. PubMed ID: 15138682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to the assessment of the treatment effects of somatoform disorders.
    Rief W; Hiller W
    Psychosomatics; 2003; 44(6):492-8. PubMed ID: 14597684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization.
    Fink P; Ewald H; Jensen J; Sørensen L; Engberg M; Holm M; Munk-Jørgensen P
    J Psychosom Res; 1999 Mar; 46(3):261-73. PubMed ID: 10193917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of the somatoform dissociation questionnaire (SDQ-5) as a screening instrument for dissociative disorders.
    Nijenhuis ER; Spinhoven P; van Dyck R; van der Hart O; Vanderlinden J
    Acta Psychiatr Scand; 1997 Nov; 96(5):311-8. PubMed ID: 9395146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatoform pain disorder in the general population.
    Grabe HJ; Meyer C; Hapke U; Rumpf HJ; Freyberger HJ; Dilling H; John U
    Psychother Psychosom; 2003; 72(2):88-94. PubMed ID: 12601226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder.
    Aigner M; Förster-Streffleur S; Prause W; Freidl M; Weiss M; Bach M
    Soc Psychiatry Psychiatr Epidemiol; 2006 Jan; 41(1):81-6. PubMed ID: 16341612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DSM-IV nosology of chronic pain: a comparison of pain disorder and multiple somatization syndrome.
    Hiller W; Heuser J; Fichter MM
    Eur J Pain; 2000; 4(1):45-55. PubMed ID: 10833555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter gene promoter polymorphism and somatoform symptoms.
    Hennings A; Zill P; Rief W
    J Clin Psychiatry; 2009 Nov; 70(11):1536-9. PubMed ID: 19538902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric characteristics of the somatoform dissociation questionnaire: a replication study.
    Nijenhuis ER; Spinhoven P; van Dyck R; van der Hart O; Vanderlinden J
    Psychother Psychosom; 1998; 67(1):17-23. PubMed ID: 9491436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Examination of the stability of medically unexplained symptoms and somatoform disorders over time within the context of different diagnostic concepts].
    Steinbrecher N; Hiller W
    Psychother Psychosom Med Psychol; 2011 Aug; 61(8):356-63. PubMed ID: 21544767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification characteristics of the Patient Health Questionnaire-15 for screening somatoform disorders in a primary care setting.
    Körber S; Frieser D; Steinbrecher N; Hiller W
    J Psychosom Res; 2011 Sep; 71(3):142-7. PubMed ID: 21843748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Readiness for behavioural change in somatoform disorders].
    Heider J; Zaby A; Schröder A
    Psychother Psychosom Med Psychol; 2006; 56(9-10):414-20. PubMed ID: 17031773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Somatoform pain and work capacity].
    Wölk W
    Versicherungsmedizin; 1992 Apr; 44(2):49-53. PubMed ID: 1604762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.